Stage II Prostate Adenocarcinoma AJCC v7

specific

Stage III includes: T3a-b, N0, M0, Any PSA, Any Gleason. cT3a: Tumor with extracapsular extension (unilateral or bilateral). pT3a: Tumor with extraprostatic extension or microscopic invasion of bladder neck. T3b: Tumor invades seminal vesicle(s). cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. (AJCC 7th ed.)

54

Centers

34

Active Trials

Cancer Funding

Top Centers for Stage II Prostate Adenocarcinoma AJCC v7(54)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.0
2
NCI Comprehensive
Active Research Program
59.3
3
NCI Comprehensive
Active Research Program
59.3
4
NCI Comprehensive
Active Research Program
59.3
5
NCI Comprehensive
Active Research Program
59.3
6
NCI Comprehensive
Active Research Program
59.3
7
NCI Comprehensive
Active Research Program
59.3
8
NCI Comprehensive
Active Research Program
59.3
9
NCI Comprehensive
Active Research Program
59.3
10
NCI Comprehensive
Active Research Program
59.3
1159.3
12
NCI Comprehensive
Active Research Program
59.3
13
NCI Comprehensive
Active Research Program
59.3
14
NCI Comprehensive
Active Research Program
59.3
15
NCI Comprehensive
Active Research Program
59.3
16
NCI Comprehensive
Active Research Program
59.3
17
Active Research Program
59.3
18
Active Research Program
59.3
19
NCI Clinical
Active Research Program
59.3
20
NCI Comprehensive
Active Research Program
59.3
21
NCI Comprehensive
Active Research Program
59.3
22
Active Research Program
59.3
23
NCI Comprehensive
Active Research Program
59.3
24
Active Research Program
59.3
25
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
59.3
26
Active Research Program
59.3
27
NCI Comprehensive
Active Research Program
59.3
28
Active Research Program
59.3
29
Active Research Program
59.3
30
Active Research Program
59.3
31
Active Research Program
59.3
32
Active Research Program
59.3
33
Active Research Program
59.3
34
NCI Comprehensive
37.2
35
NCI Comprehensive
37.2
36
NCI Comprehensive
37.2
3737.2
3837.2
3937.2
4037.2
41
NCI Comprehensive
37.2
42
NCI Comprehensive
37.2
4337.2
4437.2
45
Cedars-Sinai CancerLos Angeles, CA
37.2
4637.2
4737.2
4837.2
4937.2
5037.2
5137.2
5237.2
5337.2
5437.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →